BK vs IPSC · P/E 17, $94.14B cap vs rev $109.2M
The Bank of New York Mellon Corporation (BK) versus Century Therapeutics Inc (IPSC) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. IPSC currently screens at market cap $47.8M.
Not investment advice. Open the BK and IPSC stock pages for the full models.
Not investment advice.